Absci to Participate in Upcoming November 2021 Investor Conferences

Rhea-AI Summary

Absci Corporation (Nasdaq: ABSI), a leader in drug and target discovery utilizing deep learning AI and synthetic biology, announced its participation in two upcoming virtual investor conferences. The Credit Suisse 30th Annual Healthcare Conference will feature a fireside chat on November 9 at 10:00 a.m. PT, while the Stifel 2021 Virtual Healthcare Conference will host a fireside chat on November 16 at 1:40 p.m. PT. Interested parties can access webcasts of the presentations on the company's website.

VANCOUVER, Wash., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will be participating virtually in the following investor conferences.

• Credit Suisse 30^th Annual Healthcare Conference
  Fireside Chat on Tuesday, November 9^th at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time
  
  
• Stifel 2021 Virtual Healthcare Conference
  Fireside Chat on Tuesday, November 16^th at 1:40 p.m. Pacific Time / 4:40 p.m. Eastern Time

Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at: www.absci.com.

About Absci

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com and follow us on social media: Twitter: @Abscibio, LinkedIn: @absci.

Availability of Other Information about Absci

Investors and others should note that we routinely communicate with investors and the public using our website (www.absci.com) and the “Investors” section of our website (investors.absci.com), including without limitation, through the posting of investor presentations, SEC filings, press releases, public conference calls and webcasts on these websites. The information that we post on these websites could be deemed to be material information. As a result, investors, the media, and others interested in Absci are encouraged to review this information on a regular basis. The contents of our website, or any other website that may be accessed from our website, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Investor Contact
investors@absci.com

Media Contact
press@absci.com

FAQ

What conferences is Absci participating in during November 2021?

Absci will participate in the Credit Suisse 30th Annual Healthcare Conference on November 9 and the Stifel 2021 Virtual Healthcare Conference on November 16, 2021.

What time are Absci's presentations scheduled for November 2021?

The fireside chat at the Credit Suisse conference is on November 9 at 10:00 a.m. PT, and the chat at the Stifel conference is on November 16 at 1:40 p.m. PT.

Where can I access the webcasts for Absci's conferences?

Webcasts of Absci's conference presentations can be accessed on their website in the 'Investors' section.

What is Absci's focus in the biotechnology sector?

Absci focuses on drug and target discovery by leveraging deep learning AI and synthetic biology to enhance the therapeutic potential of proteins.

What is the ticker symbol for Absci Corporation?

The ticker symbol for Absci Corporation is ABSI.